Coagulation factor ix, Proteínas

NOVIX 50 UI/ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE

40 - 62,5 UI + 0,2 - 0,6 mg polvo y disolvente para solución inyectableSpainWithdrawnAuthorised 18 Feb 2004

This page is kept for reference and is not offered to search engines.

Packs

Pack	Code	Status
NOVIX 50 UI/ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de disolvente	816843
NOVIX 50 UI/ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de 500 UI + 1 jeringa precargada de disolvente	816850
NOVIX 50 UI/ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de 1.000 UI + 1 jeringa precargada de disolvente	816892
NOVIX 50 UI/ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de 1.500 UI + 1 vial de disolvente	817254

Documents

The official texts, at the regulator.

Summary of product characteristicsAEMPS

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Coagulation factor ix, Proteínas

NOVIX 50 UI/ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE

40 - 62,5 UI + 0,2 - 0,6 mg polvo y disolvente para solución inyectableSpainWithdrawnAuthorised 18 Feb 2004

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

Packs

Pack	Code	Status
NOVIX 50 UI/ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de disolvente	816843
NOVIX 50 UI/ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de 500 UI + 1 jeringa precargada de disolvente	816850
NOVIX 50 UI/ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de 1.000 UI + 1 jeringa precargada de disolvente	816892
NOVIX 50 UI/ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial de 1.500 UI + 1 vial de disolvente	817254

Documents

The official texts, at the regulator.

Summary of product characteristicsAEMPS

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Package leafletAEMPS

Register entryAEMPS

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Coagulation factor ix, Proteínas
Strength: 40 - 62,5 UI + 0,2 - 0,6 mg
Dosage form: polvo y disolvente para solución inyectable
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Withdrawn
Status in the register: Revocado
Authorised: 18 Feb 2004
Registration: 65917
Marketing authorisation holder: Instituto Grifols S.A.
Procedure: National, MRP or DCP
Supply: Uso Hospitalario